362 related articles for article (PubMed ID: 26823755)
21. Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma.
Guo W; Dong Z; Shi Y; Liu S; Liang J; Guo Y; Guo X; Shen S; Shan B
Dig Liver Dis; 2016 Aug; 48(8):961-9. PubMed ID: 27338851
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of miR-335 predicts a favorable prognosis in esophageal squamous cell carcinoma.
Zhang BJ; Gong HY; Zheng F; Liu DJ; Liu HX
Int J Clin Exp Pathol; 2014; 7(9):6213-8. PubMed ID: 25337272
[TBL] [Abstract][Full Text] [Related]
23. A novel long non-coding RNA FOXCUT and mRNA FOXC1 pair promote progression and predict poor prognosis in esophageal squamous cell carcinoma.
Pan F; Yao J; Chen Y; Zhou C; Geng P; Mao H; Fang X
Int J Clin Exp Pathol; 2014; 7(6):2838-49. PubMed ID: 25031703
[TBL] [Abstract][Full Text] [Related]
24. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.
Yang H; Wei YN; Zhou J; Hao TT; Liu XL
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965
[TBL] [Abstract][Full Text] [Related]
25. [Expression level and clinical significance of LncRNA HOXA11-AS in esophageal squamous cell carcinoma patients].
Sun XY; Wang XF; Cui YB; Cao XG; Zhao RH; Wei HY; Cao W; Wu W
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):186-190. PubMed ID: 29575836
[No Abstract] [Full Text] [Related]
26. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK
Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753
[TBL] [Abstract][Full Text] [Related]
27. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.
Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of uc.189 in patients with esophageal squamous cell carcinoma and its clinicopathologic value.
Guo Y; Wang C; Miao X; Chen S; Qian Y; Li G; Jiang Y
Pathol Res Pract; 2017 Nov; 213(11):1400-1403. PubMed ID: 28941722
[TBL] [Abstract][Full Text] [Related]
29. The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma.
Han T; Wang Z; Yang Y; Shu T; Li W; Liu D; Li P; Qi R; Ren Y; Li L; Liu H; Zhang S; Zhang L
Oncol Rep; 2015 Sep; 34(3):1353-60. PubMed ID: 26135942
[TBL] [Abstract][Full Text] [Related]
30. High-risk human papillomavirus infection associated with telomere elongation in patients with esophageal squamous cell carcinoma with poor prognosis.
Zhang DH; Chen JY; Hong CQ; Yi DQ; Wang F; Cui W
Cancer; 2014 Sep; 120(17):2673-83. PubMed ID: 24840723
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma.
Yue D; Fan Q; Chen X; Li F; Wang L; Huang L; Dong W; Chen X; Zhang Z; Liu J; Wang F; Wang M; Zhang B; Zhang Y
Exp Cell Res; 2014 Mar; 322(1):149-58. PubMed ID: 24269829
[TBL] [Abstract][Full Text] [Related]
32. Clinical potential of miR-3651 as a novel prognostic biomarker for esophageal squamous cell cancer.
Wang C; Guan S; Chen X; Liu B; Liu F; Han L; Un Nesa E; Song Q; Bao C; Wang X; Cheng Y
Biochem Biophys Res Commun; 2015 Sep; 465(1):30-4. PubMed ID: 26210449
[TBL] [Abstract][Full Text] [Related]
33. Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma.
Chen YF; Ma G; Cao X; Huang ZL; Zeng MS; Wen ZS
Med Oncol; 2014 Dec; 31(12):317. PubMed ID: 25377660
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of the long noncoding RNA PCAT-1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma.
Shi WH; Wu QQ; Li SQ; Yang TX; Liu ZH; Tong YS; Tuo L; Wang S; Cao XF
Tumour Biol; 2015 Apr; 36(4):2501-7. PubMed ID: 25731728
[TBL] [Abstract][Full Text] [Related]
35. PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
Kim HS; Lee SE; Bae YS; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Shin SK; Lee SK; Lee YC; Kim HR; Shim YM; Jewell SS; Kim H; Choi YL; Cho BC
Oncotarget; 2016 May; 7(21):30691-701. PubMed ID: 27095573
[TBL] [Abstract][Full Text] [Related]
36. Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma.
Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; He ZW; Zeng JX; Zhang CF
Mol Med Rep; 2017 Feb; 15(2):605-612. PubMed ID: 28000881
[TBL] [Abstract][Full Text] [Related]
37. Y-box-binding protein 1 promotes tumor progression and inhibits cisplatin chemosensitivity in esophageal squamous cell carcinoma.
Xu J; Hu Z
Biomed Pharmacother; 2016 Apr; 79():17-22. PubMed ID: 27044807
[TBL] [Abstract][Full Text] [Related]
38. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
[TBL] [Abstract][Full Text] [Related]
39. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
[TBL] [Abstract][Full Text] [Related]
40. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]